Ragini Kudchadkar: Starting a New Global Clinical Leadership Role at Daiichi Sankyo
Ragini Kudchadkar/LinkedIn

Ragini Kudchadkar: Starting a New Global Clinical Leadership Role at Daiichi Sankyo

Ragini Kudchadkar, Executive Director and Global Clinical Lead at Daiichi Sankyo, shared on LinkedIn:

“I’m very happy to share that I’ve stepped into a new role at Daiichi Sankyo as Global Clinical Lead for the Beyond Lung indications for I-DXd and gocatamig.

The past four years as Senior Medical Director for HER3-DXd have been an incredibly meaningful. I’ve had the opportunity to work with talented colleagues, learn from so many people along the way, and contribute to a program with the potential to make a difference for patients.

I’m deeply grateful to the people who have supported, challenged, and encouraged me throughout this journey. I’m excited for this next chapter!”

Daiichi Sankyo and Merck Withdraw Ifinatamab Deruxtecan BLA for Previously Treated Extensive-Stage SCLC
Ragini Kudchadkar